Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infectionMethods Published on 2021-07-252022-10-28 Journal: Antibody Therapeutics [Category] COVID-19, [키워드] acute respiratory syndrome approach authors Biomarker cellular coronavirus COVID-19 dataset Decay kinetics durability of immune response estimate example half-live heterogeneity immunology Longitudinal data marker methodology mixed-effects modeling molecular natural immunity Neutralizing titer population PK/PD pseudovirus reported SARS-CoV-2 SARS-CoV-2 immunity SARS-COV-2 infection selected statistical utility [DOI] 10.1093/abt/tbab013 PMC 바로가기 [Article Type] Methods